Evidence-aware
Safety focused
Women’s Health Clinic FAQ
Can the O-Shot improve vaginal tissue quality?
The O-Shot is commonly positioned as an intimate PRP treatment that aims to support local tissue quality, blood flow, lubrication, and sensitivity in selected patients.
Direct answer
The O-Shot is commonly positioned as an intimate PRP treatment that aims to support local tissue quality, blood flow, lubrication, and sensitivity in selected patients.
The most useful plan starts with the underlying cause, not the treatment name. Your clinician should review symptoms, medical history, alternatives, expected benefits, limitations and safety.
Educational only. Suitability must be confirmed after consultation. Results vary. Not a cure.
At a glance
These are the main points to understand before deciding whether this option is suitable.
At a glance
Clinical summary
Autologous Therapy
The treatment uses 100% of the patient’s own blood, making it highly biocompatible.
Suitability must be confirmed after consultation.
Suitability must be confirmed after consultation.
Suitability must be confirmed after consultation.
Suitability must be confirmed after consultation.
Suitability must be confirmed after consultation.
Suitability must be confirmed after consultation.
Important safety note
reported safety profile: Because the PRP is autologous (from your own body), there is virtually zero risk of allergic reaction or tissue rejection.
Suitability
Evidence
Safety
Aftercare
Detailed answer
Detailed answer
Evidence of Efficacy: Recent randomised Controlled Trials (RCTs) and scoping reviews have demonstrated that PRP injections significantly improve the Vaginal Health Index (VHI) and Female Sexual Function Index (FSFI), outperforming or matching control groups and topical oestrogen therapies in objective tissue metrics.
Clinical context
Evidence of Efficacy: Recent randomised Controlled Trials (RCTs) and scoping reviews have demonstrated that PRP injections significantly improve the Vaginal Health Index (VHI) and Female Sexual Function Index.
Evidence
Symptoms
Alternatives
What it means
Evidence of Efficacy: Recent randomised Controlled Trials (RCTs) and scoping reviews have demonstrated that PRP injections significantly improve the Vaginal Health Index (VHI) and Female Sexual Function Index.
Why it happens
Symptoms may be linked to physical, hormonal, medication-related, psychological or relationship factors.
Evidence limits
Evidence may be developing, so the page should avoid promise-based language and explain uncertainty.
Treatment fit
Suitability depends on history, symptoms, examination where appropriate and discussion of alternatives.
What this means in practice
The Blood Draw: The process begins with a standard blood draw (about 10–20 mL) from your arm. Centrifugation: The blood is spun in a specialised centrifuge for 5–10 minutes to isolate the highly concentrated Platelet-Rich Plasma.
Immediate Post-Procedure: Most women return to normal activities immediately, with minimal downtime. Short-Term (Days to Weeks): Some initial improvements in sensitivity and lubrication may be noticed within 1 to 3 weeks.
Patient safety
Why proper assessment matters
Assessment helps separate marketing claims from safe, individualised clinical decision-making.
It checks the cause
Evidence of Efficacy: Recent randomised Controlled Trials (RCTs) and scoping reviews have demonstrated that PRP injections significantly improve the Vaginal Health Index (VHI) and Female Sexual Function Index.
It protects safety
reported safety profile: Because the PRP is autologous (from your own body), there is virtually zero risk of allergic reaction or tissue rejection.
It reviews alternatives
The Blood Draw: The process begins with a standard blood draw (about 10–20 mL) from your arm.
It sets expectations
Immediate Post-Procedure: Most women return to normal activities immediately, with minimal downtime.
A clinical decision, not a shortcut
The safest final page should explain what the intervention may do, what it cannot promise, and when another route may be better.
Treatment should be discussed with realistic goals, informed consent, clear aftercare and a plan for review.
Considerations
What to consider
The Blood Draw: The process begins with a standard blood draw (about 10–20 mL) from your arm. Centrifugation: The blood is spun in a specialised centrifuge for 5–10 minutes to isolate the highly concentrated Platelet-Rich Plasma.
Consultation priorities
Consultation: A thorough evaluation with a clinician to ensure symptoms are not due to an underlying condition that requires different medical care (like severe prolapse).
Consent
Aftercare
Follow-up
Before treatment
Consultation: A thorough evaluation with a clinician to ensure symptoms are not due to an underlying condition that requires different medical care (like severe prolapse).
During care
The clinician should explain the procedure, likely sensations, limits and alternatives.
Aftercare
Written aftercare and follow-up should be clear before the patient leaves.
When to reassess
If expected improvement does not occur, the plan should be reviewed rather than repeated automatically.
Practical expectations
Immediate Post-Procedure: Most women return to normal activities immediately, with minimal downtime.
Costs, access and treatment plans should be confirmed before booking.
Common concerns and myths
Common misconceptions
Clear patient information should correct over-simple claims and keep expectations realistic.
Myth: Tissue quality can be judged by appearance alone.
Reality: suitability depends on the symptom pattern, medical history, contraindications, alternatives and individual goals.
Myth: PRP creates the same tissue response in every patient.
Reality: results vary, evidence may be developing, and non-response should prompt reassessment.
Myth: Vaginal rejuvenation is one standard procedure.
Reality: injections, devices and intimate procedures can still carry risks and need proper consent and aftercare.
Evidence and advertising
Marketing language should not outrun clinical evidence.
Alternatives
The Blood Draw: The process begins with a standard blood draw (about 10–20 mL) from your arm.
Safety checklist
Safety checklist
Use these questions to decide whether treatment should be discussed, delayed or redirected.
Has the cause been assessed?
Symptoms should be reviewed in context before selecting a treatment.
Are red flags absent?
reported safety profile: Because the PRP is autologous (from your own body), there is virtually zero risk of allergic reaction or tissue rejection.
Are alternatives clear?
The Blood Draw: The process begins with a standard blood draw (about 10–20 mL) from your arm.
Is follow-up planned?
The clinic should explain aftercare, review timing and when to seek help.
Reassuring signs
Proceeding is more reasonable when goals are clear, red flags have been checked, and expectations are realistic.
No red flags
Follow-up plan
Reasons to pause
reported safety profile: Because the PRP is autologous (from your own body), there is virtually zero risk of allergic reaction or tissue rejection.
Bleeding
Infection
When to escalate
When to seek medical help
Some symptoms should be assessed before any elective intimate treatment. Use NHS 111 online
Severe or worsening pain
reported safety profile: Because the PRP is autologous (from your own body), there is virtually zero risk of allergic reaction or tissue rejection.
Bleeding or discharge
Unexplained bleeding, unusual discharge or new pelvic symptoms should be reviewed.
Infection signs
Fever, spreading redness, pus or feeling unwell after a procedure needs urgent advice.
Emergency symptoms
Call 999 in a life-threatening emergency, including collapse, chest pain or breathing difficulty.
Use NHS 111 for urgent advice or call 999 in a life-threatening emergency. This page is educational and does not replace individual medical assessment.
More clinical detail
Benchmark positioning
- The winning page owns the science without overclaiming: tissue quality is a biological context, not a simple aesthetic promise.
Clinical reality
- Evidence of Efficacy: Recent randomised Controlled Trials (RCTs) and scoping reviews have demonstrated that PRP injections significantly improve the Vaginal Health Index (VHI) and Female Sexual Function Index (FSFI), outperforming or matching control groups.
Timeline and expectations
- Immediate Post-Procedure: Most women return to normal activities immediately, with minimal downtime. Short-Term (Days to Weeks): Some initial improvements in sensitivity and lubrication may be noticed within 1 to 3 weeks.
Practical logistics
- The Blood Draw: The process begins with a standard blood draw (about 10–20 mL) from your arm.
Research sources
- Willison, N. et al. (2025). Application of Platelet-Rich Plasma in Gynaecologic Disorders: A Scoping Review. Journal of Clinical Medicine. | Atlihan, U. et al. (2025).
Regulatory resources
Authoritative resources
These resources support assessment-led, evidence-aware patient information.
NICE interventional procedures guidance
NICE is a UK authority for interventional procedure governance and supports cautious language about evidence, consent and audit.
FDA safety communication on vaginal rejuvenation devices
This safety communication is a useful regulatory reference for avoiding over-claiming around sexual enhancement procedures.
RCOG patient information on menopause symptom treatment
RCOG patient information supports assessment-led discussion of vaginal dryness, discomfort and hormone-related symptoms.
Next step
Book a clinical consultation
A consultation can confirm whether this treatment may be suitable, whether another pathway should come first, and what realistic outcomes and aftercare would look like.
▶ View Research Sources (12 Sources)
These 12 source names are selected from 24 display-ready sources, with a raw audit trail of 168 imported records. Additional reviewed material included peer-reviewed clinical papers, evidence reviews; duplicate, low-relevance and non-clinical records were removed before display.
Educational only. Medical Disclaimer: This information is provided for educational and informational purposes only and does not constitute medical advice. While vaginal PRP therapy uses a patient's own biological material and has a reported safety profile, it is an elective, off-label procedure. Outcomes depend heavily on individual biological factors, hormonal health, and the specific protocols used by your provider. Always consult a qualified, licensed healthcare professional to undergo a comprehensive clinical assessment and determine if this treatment is safe and appropriate for your specific health needs. Results vary. Not a cure.
